...
首页> 外文期刊>Acta Biochimica Polonica >Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs)
【24h】

Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs)

机译:肠道微生物胺衍生短链脂肪酸(SCFA)的免疫调节潜力

获取原文
获取原文并翻译 | 示例
           

摘要

Intestinal microbiota is an element of the bacterial ecosystem in all mammalian organisms. These microorganisms play a very important part in the development, functioning, and modulation of the immune system from the moment of birth. In recent years, owing to the use of modern sequencing techniques, the microbiome composition in healthy people has been identified based on bacterial 16S rRNA analysis. Currently, more and more attention is being given to the influence of microorganisms on the host's cellular metabolism. Analysis of microbial metabolites, among them short-chain fatty acids (SCFAs), and disruption of intestinal microbiota homeostasis in terms of their effects on molecular regulatory mechanisms of immune reactions will surely improve the understanding of the etiology of many common diseases. SCFAs, mainly butyrate, propionate, and acetate, occur in specific amounts, and their proportions can change, depending on the diet, age and diseases. The levels of SCFAs are substantially influenced by the ratio of commensal intestinal bacteria, the disturbance of which (dysbiosis) can lead to a disproportion between the SCFAs produced. SCFAs are regarded as mediators in the communication between the intestinal microbiome and the immune system. The signal they produce is transferred, among others, in immune cells via free fatty acid receptors (FFARs), which belong to the family of G protein-coupled receptors (GPCRs). It has been also confirmed that SCFAs inhibit the activity of histone deacetylase (HDAC) - an enzyme involved in post-translational modifications, namely the process of deacetylation and, what is new, the process of histone crotonylation. These properties of SCFAs have an effect on their immunomodulatory potential i.e. maintaining the anti/pro-inflammatory balance. SCFAs act not only locally in the intestines colonized by commensal bacteria, but also influence the intestinal immune cells, and modulate immune response by multi-protein inflammasome comple
机译:肠道微生物群是所有哺乳动物生物中的细菌生态系统的一个元素。这些微生物在从出生时期发挥显影,运作和调制的显着作用。近年来,由于使用现代测序技术,已经基于细菌16s rRNA分析鉴定了健康人中的微生物组成。目前,越来越多地关注微生物对宿主细胞新陈代谢的影响。微生物代谢物的分析,其中短链脂肪酸(SCFA),以及在其对免疫反应的分子调节机制的影响方面,肠道微生物骨稳态的破坏肯定会改善对许多常见疾病的病因的理解。 SCFA,主要是丁酸酯,丙酸盐和醋酸盐,以特定量发生,其比例可以根据饮食,年龄和疾病而变化。 SCFA的水平基本上受到共生肠道细菌的比例的影响,其中(困难)的干扰可以导致产生的SCFA之间的不成比例。 SCFA被认为是肠道微生物组和免疫系统之间的沟通中的介质。它们产生的信号通过游离脂肪酸受体(FFARs)在免疫细胞中转移,其属于G蛋白偶联受体(GPCR)的家族。还证实,SCFA抑制组蛋白脱乙酰化酶(HDAC)的活性 - 一种参与翻译后修饰的酶,即脱乙酰化的过程,以及新的,组蛋白克拉多内的过程。 SCFA的这些性质对其免疫调节潜力有影响,即保持抗/促炎症平衡。 SCFA不仅在广泛的细菌殖民殖民地局部行动,而且影响肠道免疫细胞,并通过多蛋白炎症组合调节免疫应答

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号